INTEGRA Cancer Institute ( Site 0155)

Guatemala City 01010

0 studies enrolling now · 1 studies all time

What they study most

Breast Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) — Running, not enrolling